Track topics on Twitter Track topics that are important to you
Ewert House, Ewert Place
Phone: 44 (0)1865 280830
Fax: 44 (0)1865 280831
Adam Stoten, head of Technology Transfer at Isis Innovation (the technology transfer arm of the University of Oxford) discusses the recent successes of Oxford Sciences Innovation (OSI), a fund compris...
Isis Pharmaceuticals (Carlsbad, CA) has initiated a Phase II clinical trial of Isis 2503, its third antisense anticancer compound in clinical development...
GSK and Isis to develop up to 6 drugs for rare and serious diseases
Genzyme and Isis announce positive phase III trials for inherited high LDL drug
A look at today's forthcoming news stories: GSK and Isis in US$ 1.5B deal to develop rare disease drugs; sanofi changes direction towards biotechnology, and Glaxo gets approval for Avodart in combinat...
International, professional and marketing level of the Innovation and Entrepreneurship Fair is continuously improving and is becoming the powerful drive to implement the innovation-driven developmen...
A look at today's forthcoming news stories including Genzyme and Isis announcing positive trials for rare cholesterol condition; Novartis wins European approval for meningitis vaccine and the cannabis...
Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash
EYEWASH STATION ADDITIVE CONCENTRATE
Measurement of mortality and injury in conflict situations presents many challenges compared with stable situations. However, providing information is important to assess the impact of conflict on pop...
Following an ISIS attack, the present study examined the association between psychological distress and severe stress symptoms with vulnerability variables: i.e. Physical proximity to the site of the ...
Recent research has indicated that the interval between inseminations in modern dairy cattle is often longer than the commonly accepted cycle length of 18-24 days. This study analysed 257,396 insemina...
Innovation is a part of the daily practice of neurosurgery. A clear definition of what constitutes innovation is currently lacking, however, and opinions vary from continent to continent, from hospita...
Manufacturing in China has developed rapidly with the widening and deepening of globalization, but only innovation can industry keep upgrading and enhancing its international competitiveness. This pap...
A Double Blind, Placebo-Controlled, Dose-Escalation, Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ISIS 353512 Administered Intravenously and Subcutaneously to Healthy Volunteers
The purpose of this study is to evaluate the safety and tolerability of single and multiple doses of ISIS 353512, to evaluate the blood concentration and rate elimination of ISIS 353512 fr...
The aim of this study is to assess the safety of varying doses of ISIS 301012 in subjects on Stable statin therapy.
The aim of this study is to assess the safety and efficacy of varying doses of ISIS 301012 as add-on therapy in subjects with Heterozygous Familial Hypercholesterolemia
To evaluate the efficacy and safety of ISIS 2922 in AIDS patients with Cytomegalovirus ( CMV ) retinitis who are unresponsive or intolerant to ganciclovir and/or foscarnet but are otherwis...
The primary objective of the study is to examine the efficacy of multiple doses of ISIS SMNRx (ISIS 396443) administered intrathecally in preventing or delaying the need for respiratory in...
Isis Innovation is the technology transfer company of the University of Oxford, commercialising the research generated by University researchers and owned by the University.Isis Innovation Ltd is a wh...
Isis Parenting is the nationâs leading provider of prenatal and early parenting education. Isis partners with leading healthcare institutions to offer over their patients ove...
Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...
Isis Pharmaceuticals, Inc. is a leading drug discovery and development company, focused exclusively on the therapeutic target, RNA. Founded in 1989, Isis' mission is to develop products from its RNA-b...
We have published hundreds of Isis Innovation news stories on BioPortfolio along with dozens of Isis Innovation Clinical Trials and PubMed Articles about Isis Innovation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Isis Innovation Companies in our database. You can also find out about relevant Isis Innovation Drugs and Medications on this site too.